Answers are grounded in this paper and cite their sources.
Background Osteochondral lesions of the talus (OLTs) are challenging to treat due to the limited regenerative capacity of hyaline cartilage. Emerging cell-free scaffolds such as ChondroFiller offer a single-stage, minimally invasive option; however, evidence regarding their clinical and radiological outcomes in ankle lesions remains limited. Methods This multicenter retrospective cohort study included 21 patients with magnetic resonance imaging (MRI)-confirmed OLTs (Hepple grades III-V) treated arthroscopically with ChondroFiller between October 2023 and October 2025. Autologous cancellous bone grafting was performed in cases with subchondral defects. Clinical outcomes were assessed using the foot and ankle outcome score (FAOS) and visual analog scale (VAS), while cartilage repair was evaluated using the magnetic resonance observation of cartilage repair tissue (MOCART 2.0) score on postoperative MRI at a minimum follow-up of 6 months. Statistical analysis included paired comparisons and correlation testing. Results At a mean follow-up of 20.7 ± 7.8 months, significant improvements were observed in all clinical parameters. Mean FAOS improved from 52.7 ± 11.3 preoperatively to 85.0 ± 7.7 postoperatively (P < .001), with all subdomains showing significant gains. Mean VAS decreased from 7.90 ± 1.1 to 1.05 ± 1.2 (P < .001). The mean MOCART score was 55.0 ± 7.9, indicating moderate structural repair. No significant correlation was found between MOCART scores and clinical outcomes (VAS: ρ = 0.111, P = .632; FAOS: ρ = −0.216, P = .347). No major complications or revision procedures were reported. Conclusion Arthroscopic application of ChondroFiller for OLTs demonstrates significant short- to mid-term improvements in pain and functional outcomes, despite only moderate radiological repair. The lack of correlation between imaging and clinical outcomes highlights the importance of patient-reported measures in evaluating treatment success. Further prospective studies with longer follow-up are required to validate these findings. Levels of Evidence: IV retrospective case series
No takes yet. Share an insight, caveat, or question.
Simon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: